Australian bio-pharmaceutical developer Zelda Therapeutics (ASX: ZLD) has now fully enrolled insomnia sufferers into clinical trials where the Company aims to use cannabis as a treatment for clinically diagnosed patients. This set of trials will be completed in collaboration with the University of Western Australia (UWA) Centre for Sleep Science. The trials will aim to
Read More
Australian bio-pharmaceutical company Zelda Therapeutics (ASX: ZLD) has continued advancing its observational study which is revealing data around the use of medicinal cannabis for improved behaviour in autistic children. Being conducted at the Children’s Hospital of Philadelphia, the observational study uses parent-reported data to identify doses and formulations of cannabis that improve behaviour, anxiety, sleep,
Read More